infectious-disease immunology
HIV Opportunistic Infection Risk (CD4-Based)
Predicts risk of specific opportunistic infections by CD4 count threshold. Guides prophylaxis and diagnostic priorities in HIV-positive patients.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Emollient bath and shower products, paraffin-containing · Paraffin-based bath/shower emollient
- Emollient creams and ointments, hydrogenated castor oil-containing · Hydrogenated castor oil-based emollient
- Dimeticone · Topical pediculicide (silicone-based)
- Anti-D (Rh₀) Immunoglobulin · Immunoglobulin (Rh Prophylaxis)
- Cefuroxime · Second-Generation Cephalosporin — Respiratory / Surgical Prophylaxis
Pathways
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.